Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorDuke University
About this trial
The purpose of this protocol is to create a repository of blood samples from patients diagnosed with primary and metastatic brain tumors who are being seen in the Department of Radiation Oncology at Duke Cancer Center.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Have a confirmed diagnosis of primary or metastatic brain tumor (histology or imaging as appropriate)
Disqualifiers
None
Trial population
Patients diagnosed with primary or metastatic brain tumors and treated in the Department of Radiation Oncology at Duke
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Number of circulating immune cells in peripheral blood
reported as mean +/- standard deviation
Time frame
6 weeks post radiation therapySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov